Arcturus Therapeutics Holdings Inc (ARCT)
R&D Expenses
$86.18M
TTM · Period ending: · USD
ARCT R&D Expenses
Latest reported$86.18Mperiod ending
Latest reported$86.18Mperiod ending
ARCT TTM R&D Expenses ($7.07M → $86.18M)
TTM R&D Expenses
High-resolution chart · PNG
ARCT r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 86,181,000 | |
| 98,245,000 | |
| 112,213,000 | |
| 131,517,000 | |
| 147,386,000 | |
| 176,476,000 | |
| 195,156,000 | |
| 187,996,000 | |
| 199,939,000 | |
| 193,938,000 | |
| 192,133,000 | |
| 182,494,000 | |
| 169,105,000 | |
| 154,626,000 | |
| 147,751,000 | |
| 153,403,000 | |
| 161,113,000 | |
| 168,603,000 | |
| 173,760,000 | |
| 165,413,000 | |
| 137,714,000 | |
| 99,979,000 | |
| 57,846,000 | |
| 45,554,000 | |
| 34,908,000 | |
| 34,233,000 | |
| 33,640,000 | |
| 26,493,000 | |
| 23,409,000 | |
| 20,365,000 | |
| 16,982,000 | |
| 23,491,000 | |
| 20,581,000 | |
| 17,799,000 | |
| 15,918,000 | |
| 9,009,000 | |
| 14,350,000 | |
| 17,089,000 | |
| 18,391,000 | |
| 17,279,000 | |
| 13,732,000 | |
| 13,233,000 | |
| 13,461,000 | |
| 15,034,000 | |
| 20,938,000 | |
| 23,173,000 | |
| 25,105,000 | |
| 24,800,000 | |
| 18,110,000 | |
| 12,513,000 | |
| 7,066,000 | |
| 2,530,000 | |
| 582,000 | |
| 492,000 |